ChromaDex Corporation (CDXC) Financials

CDXC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 55.0 million 26.5 million
2023-09-30 53.5 million 26.2 million
2023-06-30 53.2 million 26.0 million
2023-03-31 53.8 million 25.8 million

CDXC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 553000 1.0 million
2023-09-30 370000 1.1 million
2023-06-30 3.3 million 1.3 million
2023-03-31 2.7 million 1.3 million

CDXC Net Income

No data available :(

CDXC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 27.3 million - 3.3 million
2023-09-30 26.6 million - 3.8 million
2023-06-30 26.3 million - 3.9 million
2023-03-31 23.1 million - 4.1 million

CDXC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 75.0 million
2023-09-30 75.1 million
2023-06-30 75.0 million
2023-03-31 74.8 million

CDXC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 21000 1.2 million 5.4 million 6.5 million
2023-09-30 26000 1.2 million 5.8 million 6.0 million
2023-06-30 10000 1.4 million 7.3 million 6.0 million
2023-03-31 91000 1.2 million 6.4 million 7.9 million

CDXC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 21.2 million 8.3 million
2023-09-30 19.5 million 7.5 million
2023-06-30 20.3 million 8.0 million
2023-03-31 22.6 million 9.0 million

CDXC

Price: $3.78

52 week price:
1.25
4.65

Earnings Per Share: -0.07 USD

P/E Ratio: -16.89

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 333600

Ebitda: -3.0 million

Market Capitalization: 299.7 million

Links: